AMD-Mamba: A Phenotype-Aware Multi-modal Framework for Robust AMD Prognosis.

Puzhen Wu, Mingquan Lin, Qingyu Chen, Emily Y Chew, Zhiyong Lu, Yifan Peng, Hexin Dong
{"title":"AMD-Mamba: A Phenotype-Aware Multi-modal Framework for Robust AMD Prognosis.","authors":"Puzhen Wu, Mingquan Lin, Qingyu Chen, Emily Y Chew, Zhiyong Lu, Yifan Peng, Hexin Dong","doi":"10.1007/978-3-032-09513-8_15","DOIUrl":null,"url":null,"abstract":"<p><p>Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss, making effective prognosis crucial for timely intervention. In this work, we propose AMD-Mamba, a novel multi-modal framework for AMD prognosis, and further develop a new AMD biomarker. This framework integrates color fundus images with genetic variants and socio-demographic variables. At its core, AMD-Mamba introduces an innovative metric learning strategy that leverages AMD severity scale score as prior knowledge. This strategy allows the model to learn richer feature representations by aligning learned features with clinical phenotypes, thereby improving the capability of conventional prognosis methods in capturing disease progression patterns. In addition, unlike existing models that use traditional CNN backbones and focus primarily on local information, such as the presence of drusen, AMD-Mamba applies Vision Mamba and simultaneously fuses local and long-range global information, such as vascular changes. Furthermore, we enhance prediction performance through multi-scale fusion, combining image information with clinical variables at different resolutions. We evaluate AMD-Mamba on the AREDS dataset, which includes 45,818 color fundus photographs, 52 genetic variants, and 3 socio-demographic variables from 2,741 subjects. Our experimental results demonstrate that our proposed biomarker is one of the most significant biomarkers for the progression of AMD. Notably, combining this biomarker with other existing variables yields promising improvements in detecting high-risk AMD patients at early stages. These findings highlight the potential of our multi-modal framework to facilitate more precise and proactive management of AMD.</p>","PeriodicalId":74092,"journal":{"name":"Machine learning in medical imaging. MLMI (Workshop)","volume":"16241 ","pages":"150-160"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12790706/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Machine learning in medical imaging. MLMI (Workshop)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-032-09513-8_15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss, making effective prognosis crucial for timely intervention. In this work, we propose AMD-Mamba, a novel multi-modal framework for AMD prognosis, and further develop a new AMD biomarker. This framework integrates color fundus images with genetic variants and socio-demographic variables. At its core, AMD-Mamba introduces an innovative metric learning strategy that leverages AMD severity scale score as prior knowledge. This strategy allows the model to learn richer feature representations by aligning learned features with clinical phenotypes, thereby improving the capability of conventional prognosis methods in capturing disease progression patterns. In addition, unlike existing models that use traditional CNN backbones and focus primarily on local information, such as the presence of drusen, AMD-Mamba applies Vision Mamba and simultaneously fuses local and long-range global information, such as vascular changes. Furthermore, we enhance prediction performance through multi-scale fusion, combining image information with clinical variables at different resolutions. We evaluate AMD-Mamba on the AREDS dataset, which includes 45,818 color fundus photographs, 52 genetic variants, and 3 socio-demographic variables from 2,741 subjects. Our experimental results demonstrate that our proposed biomarker is one of the most significant biomarkers for the progression of AMD. Notably, combining this biomarker with other existing variables yields promising improvements in detecting high-risk AMD patients at early stages. These findings highlight the potential of our multi-modal framework to facilitate more precise and proactive management of AMD.

AMD- mamba:一个表型敏感的多模态框架稳健的AMD预后。
年龄相关性黄斑变性(AMD)是导致不可逆视力丧失的主要原因,有效的预后对及时干预至关重要。在这项工作中,我们提出AMD- mamba,一个新的多模态的AMD预后框架,并进一步开发新的AMD生物标志物。该框架整合了彩色眼底图像与遗传变异和社会人口变量。在其核心,AMD- mamba引入了一种创新的度量学习策略,利用AMD严重性量表得分作为先验知识。该策略允许模型通过将学习到的特征与临床表型对齐来学习更丰富的特征表示,从而提高传统预后方法捕捉疾病进展模式的能力。此外,与现有模型使用传统的CNN骨干网,主要关注局部信息(如是否存在drusen)不同,AMD-Mamba采用Vision Mamba,同时融合局部和远程全局信息(如血管变化)。此外,我们通过多尺度融合,将图像信息与不同分辨率的临床变量相结合,提高预测性能。我们在AREDS数据集上评估AMD-Mamba,该数据集包括来自2,741名受试者的45,818张彩色眼底照片,52个遗传变异和3个社会人口统计学变量。我们的实验结果表明,我们提出的生物标志物是AMD进展中最重要的生物标志物之一。值得注意的是,将这种生物标志物与其他现有变量相结合,在早期发现高风险AMD患者方面有希望得到改善。这些发现突出了我们的多模态框架在促进AMD更精确和主动管理方面的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书